{"title":"Experience with remote electronic portal imaging device-based dosimetric auditing for static and rotational intensity modulated radiotherapy.","authors":"Peter B Greer, Joerg Lehmann, Alisha Moore","doi":"10.1016/j.phro.2024.100674","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this work was to evaluate results of a remote electronic portal imaging based dosimetric auditing method using Task-Group 218 clinical gamma evaluation criteria (3%,2 mm, 10% dose threshold). For intensity modulated radiation therapy the results were (mean ± 1 SD) 97.9 ± 4.5% with 31/34 audits passing (optimal level, <math><mo>≥</mo></math> 95%) and 3/34 audits failing (action level, <math><mo><</mo></math> 90%). For volumetric modulated arc therapy the results were 98.5 ± 2.3% with 32/36 audits passing (optimal level) and 4/36 passing (tolerance level, <math><mo>≥</mo></math> 90% and <math><mo><</mo></math> 95%). The audit has been successfully applied globally for clinical trial quality assurance.</p>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"32 ","pages":"100674"},"PeriodicalIF":3.4000,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663962/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics and Imaging in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.phro.2024.100674","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The aim of this work was to evaluate results of a remote electronic portal imaging based dosimetric auditing method using Task-Group 218 clinical gamma evaluation criteria (3%,2 mm, 10% dose threshold). For intensity modulated radiation therapy the results were (mean ± 1 SD) 97.9 ± 4.5% with 31/34 audits passing (optimal level, 95%) and 3/34 audits failing (action level, 90%). For volumetric modulated arc therapy the results were 98.5 ± 2.3% with 32/36 audits passing (optimal level) and 4/36 passing (tolerance level, 90% and 95%). The audit has been successfully applied globally for clinical trial quality assurance.